
Expand
Image: CNBC Top News
Updated
Hims & Hers launched compounded forms of sermorelin, glutathione, NAD+, vitamin B-12 and L-carnitine, CNBC Top News reported on November 18, 2026. None of the compounded treatments is approved by the FDA, and the company acknowledged there is more to learn about their efficacy.
Sources:CNBC Top News